Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Cannabist Co Holdings (CBSTF) Capital Expenditures (2021 - 2025)

Historic Capital Expenditures for Cannabist Co Holdings (CBSTF) over the last 5 years, with Q3 2025 value amounting to $248000.0.

  • Cannabist Co Holdings' Capital Expenditures fell 8366.27% to $248000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.8 million, marking a year-over-year decrease of 111.05%. This contributed to the annual value of $5.8 million for FY2024, which is 4149.11% down from last year.
  • According to the latest figures from Q3 2025, Cannabist Co Holdings' Capital Expenditures is $248000.0, which was down 8366.27% from $1.8 million recorded in Q2 2025.
  • In the past 5 years, Cannabist Co Holdings' Capital Expenditures registered a high of $45.2 million during Q4 2021, and its lowest value of $16000.0 during Q2 2023.
  • Its 5-year average for Capital Expenditures is $11.1 million, with a median of $2.5 million in 2023.
  • As far as peak fluctuations go, Cannabist Co Holdings' Capital Expenditures crashed by 9994.51% in 2023, and later skyrocketed by 1030000.0% in 2024.
  • Cannabist Co Holdings' Capital Expenditures (Quarter) stood at $45.2 million in 2021, then plummeted by 92.52% to $3.4 million in 2022, then plummeted by 49.51% to $1.7 million in 2023, then decreased by 1.29% to $1.7 million in 2024, then plummeted by 85.27% to $248000.0 in 2025.
  • Its last three reported values are $248000.0 in Q3 2025, $1.8 million for Q2 2025, and $2.0 million during Q1 2025.